GL1X · GenesisL1 explorer

MolNFT v1 · #53947 · protein

Inhibitors of JAK2 kinase domain

2XA4 · Tyrosine-protein kinase JAK2: “Inhibitors of JAK2 kinase domain”. X-ray diffraction, 1 ligand (AZ5), 5 pockets (best druggability 0.72). MolNFT v1 #53947 on GenesisL1: 3D structure, binding sites and pockets in GL1X.

PDB
2XA4
Type
protein
Length
555 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Tyrosine-protein kinase JAK2
EC
2.7.1.112, 2.7.10.2
UniProt
O60674
Ligands
AZ5
Pockets
5 · best druggability 0.72

Structure

x-ray diffraction · 2 distinct chains · 45% helix, 18% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ATyrosine-protein kinase JAK2 (EC 2.7.1.112, 2.7.10.2)protein27846% helix, 19% strandO60674
BTyrosine-protein kinase JAK2 (EC 2.7.1.112, 2.7.10.2)protein27745% helix, 18% strandO60674

Ligands and binding sites

  • AZ5 · 5-chloro-N2-[(1S)-1-(5-fluoropyrimidin-2-yl)ethyl]-N4-(5-methyl-1H-pyrazol-3-yl)pyrimidine-2,4-diamine · ligand · 2 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

5 pockets found on a 1 Å grid, 4 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
19230.720.7663empty
22250.630.8225AZ5
33330.620.7841AZ5
41800.580.8134empty
5690.310.7422empty

Interfaces

1 interface between chains.

  • A–B · 399 Ų buried · 8 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 4 modified (phosphorylation).

Compared structures

  • 2XA4 · Inhibitors of Jak2 Kinase domain · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.